Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -0.485\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) Cc1ccc(S(=O)(=O)CCC(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)cc1
(b) CCCCN1CCC(COC(=O)c2cc(Cl)c(N)c3c2OCCO3)CC1.Cl
(c) Brc1ccc(-c2nn3c(-c4ccco4)nnc3s2)o1
(d) N#Cc1cc2c(nc1SCc1nc3ccccc3[nH]1)CCC2
Answer: d. N#Cc1cc2c(nc1SCc1nc3ccccc3[nH]1)CCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#Cc1cc2c(nc1SCc1nc3ccccc3[nH]1)CCC2
N#Cc1cc2c(nc1SCc1nc3ccccc3[nH]1)CCC2
2-(1H-benzimidazol-2-ylmethylsulfanyl)-6,7-dihydro-5H-cyclopenta[b]pyridine-3-carbonitrile